Furthermore, genetic modification with FoxP3 and Bcl-xL using vectors containing the 2A sequence is able to generate highly reactive Tregs that could be used for augmented cellular immunotherapy for autoimmune disease. Here, BCL2L1 is linked to autoimmune disease.